CEO Ron Cooper said the company’s lead product candidate, detalimogene, is being developed with an eye toward the practical needs of urologists treating high-risk non-muscle invasive bladder cancer ...
NineDot Energy Completes $431 Million Financing With Natixis For 28 Battery Energy Storage Projects In NYC, Bringing Total ...